Breathe Easy Blog

VIDA blog posts

VIDA appoints digital health technology leader Karen Drexler to board of directors, underscoring focus on market expansion of AI solutions

By |2020-09-09T15:39:43-05:00August 11th, 2020|Breathe Easy Blog, Press Releases|

Growing bench of proven leaders in clinical lung intelligence and health technology bolsters both product and commercial advances Coralville, IA (August 11, 2020) —VIDA Diagnostics, Inc. (“VIDA”), the leader in lung and respiratory intelligence, announced today that it is has appointed Karen Drexler to its board of directors, further expanding the

Read More

Adoption of VIDA’s AI to Improve Patient Outcomes and Reduce Burnout

By |2020-07-07T13:37:13-05:00July 7th, 2020|Breathe Easy Blog|

Success Story Nuance Communications, Inc. (NASDAQ: NUAN), recently announced a success story at Einstein Healthcare in Philadelphia, where VIDA's LungPrint Discovery was deployed through the Nuance AI Marketplace, into PowerScribe™ One. Einstein Healthcare has already processed nearly 1,400 studies using LungPrint Discovery to address the diagnostic challenges of the COVID-19

Read More

Respiratory health AI trailblazer VIDA poised for increased scale with newest appointment to leadership team

By |2020-07-08T09:35:28-05:00July 7th, 2020|Breathe Easy Blog, Press Releases|

Todd Johnson joins VIDA, bringing expertise in enterprise imaging, clinical software applications to growing bench of experts for AI-powered pulmonary imaging company Coralville, IA (July  7, 2020) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, announced today that Todd Johnson has joined the company as chief

Read More

Takeaways from VIDA’s First Virtual Conference

By |2020-06-15T11:44:10-05:00June 15th, 2020|Breathe Easy Blog|

Adaptability to change has always been a core value at VIDA. So, when we saw major events canceled due to COVID-19, we were eager to find alternative ways of connecting with the industry. In this spirit, VIDA participated in its first virtual conference last month: the AuntMinnie.com virtual conference on May

Read More

AI-Powered Respiratory Imaging in and Beyond the Era of COVID-19

By |2020-08-24T15:54:18-05:00May 8th, 2020|Breathe Easy Blog, LungPrint|

A Discussion Between Thoracic Radiologist John Newell, MD, and VIDA CEO Susan Wood, PhD On May 1, 2020, during AuntMinnie's 2020 Virtual Conference, Dr. Newell and Dr. Wood discussed the evolving role of imaging for COVID-19 and the importance of a holistic, quantitative approach to managing patients with respiratory conditions. 

Read More

VIDA COMPLETES SECOND CLOSE OF ROUND C FINANCING

By |2020-04-15T13:30:49-05:00April 15th, 2020|Breathe Easy Blog, Press Releases|

$2M Second Close from Strategic Partners Completes $13M C Round to Advance AI-Powered Respiratory Solutions Coralville, IA (April 15, 2020) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, received $2M from OSF Ventures, the corporate investment arm of OSF HealthCare, as a second close of its C

Read More

VIDA Commended by Frost & Sullivan for Transforming Respiratory Disease Care Globally with its LungPrint Suite

By |2020-04-01T09:33:38-05:00April 1st, 2020|Breathe Easy Blog, LungPrint, Press Releases|

VIDA provides personalized care solutions that can help pulmonologists identify specific disease phenotypes as well as decide on the most appropriate treatments Note: The following press release was issued by Frost and Sullivan on April 1, 2020 and is republished here in full. SANTA CLARA, Calif., April 1, 2020 /CNW/ -- Based

Read More

The Role of CT in the COVID-19 Pandemic—Top 5 Takeaways

By |2020-04-01T15:41:44-05:00March 30th, 2020|Breathe Easy Blog, Literature Review|

We’d like to start off by expressing our heartfelt gratitude to the men and women in healthcare who are braving this storm, putting themselves and their families at risk for their commitment to the health and well-being of their patients‒ we see you, we support you and we want to

Read More

Anthony Chang, MD, Founder of AIMed, Speaks with Susan Wood, PhD, CEO of VIDA, About COVID-19

By |2020-04-09T16:56:55-05:00March 26th, 2020|Breathe Easy Blog|

Anthony Chang, MD, MBA, MPH, MS is a pediatric cardiologist and Chief Intelligence and Innovation Officer at CHOC Children's Orange County. He is also the founder of AIMed (Artificial Intelligence in Medicine), a media enterprise focused on artificial intelligence (AI). Dr. Chang sat down with VIDA's CEO, Susan Wood, PhD, to

Read More
VIDA is a clinical imaging intelligence company. We are accelerating the approval and adoption of lifesaving therapies to patients through our AI-powered digital biomarker solution. With proprietary imaging biomarkers for precise quantitative endpoints and exceptional trial imaging management services, VIDA’s solution is helping biopharma sponsors save millions in drug development costs. VIDA's services are enabled by the VIDA Intelligence Platform, an AI-powered system that streamlines imaging in clinical trials. The cloud platform facilitates high-quality, reliable imaging data from over 1,500 sites around the globe.

855.900.8432
info@vidalung.ai
COPYRIGHT - VIDA Diagnostics Inc.
VIDA holds regulatory clearances for clinical sales of its VIDA Insights and VIDA Discovery solutions in the US and Canada. VIDA is HIPAA compliant.
cera
Go to Top